telemedicine
Lab Owner Pleads Guilty to $73M Scheme to Defraud Medicare
The scheme involved paying kickbacks to a telemedicine company in exchange for authorizations by doctors for medically unnecessary genetic testing.
Exact Sciences Positions Itself as Cancer Testing Provider of Future as COVID Crisis Continues
The company believes the pandemic will accelerate the adoption of its cancer diagnostics as patients and doctors look for faster and more convenient tests.
Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19
The diagnostics firm is conducting a 1,000-person study to find T cell profiles associated with the immune response to COVID-19 and recovery from the disease.
Amid COVID-19 Pandemic, Exact Sciences Makes a Bet on Telehealth
The company saw orders for its Cologuard colorectal cancer test fall 63 percent during the first 20 days of April because of a decline in standard healthcare visits.
The lab company is beginning to offer the tools and services it used to contain its healthcare spending to health plans and other employers.